|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2006-4-28
|
|
pubmed:abstractText |
The aim of this study was to assess the effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0149-5992
|
|
pubmed:author |
pubmed-author:AssaloniRobertaR,
pubmed-author:CarleoDiegoD,
pubmed-author:CerielloAntonioA,
pubmed-author:CiotolaMiryamM,
pubmed-author:CozzolinoDomenicoD,
pubmed-author:EspositoKatherineK,
pubmed-author:GiuglianoDarioD,
pubmed-author:MeranteDomenicoD,
pubmed-author:SaccomannoFrancoF,
pubmed-author:SassoFerdinando CarloFC,
pubmed-author:SchisanoBrunoB
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1071-6
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16644639-Adult,
pubmed-meshheading:16644639-Blood Glucose,
pubmed-meshheading:16644639-Blood Pressure,
pubmed-meshheading:16644639-Body Size,
pubmed-meshheading:16644639-Double-Blind Method,
pubmed-meshheading:16644639-Endothelium, Vascular,
pubmed-meshheading:16644639-Female,
pubmed-meshheading:16644639-Humans,
pubmed-meshheading:16644639-Hypoglycemic Agents,
pubmed-meshheading:16644639-Inflammation,
pubmed-meshheading:16644639-Insulin,
pubmed-meshheading:16644639-Lipids,
pubmed-meshheading:16644639-Male,
pubmed-meshheading:16644639-Metabolic Syndrome X,
pubmed-meshheading:16644639-Middle Aged,
pubmed-meshheading:16644639-Thiazolidinediones
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome.
|
|
pubmed:affiliation |
Division of Metabolic Diseases, University of Naples SUN, Naples, Italy.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
